Professor Ben Solomon is a medical oncologist in the Lung Service and  Group Leader of the Molecular Therapeutics and Biomarkers Laboratory in the Research Division. He has an interest in translational lung cancer research. Following a postdoctoral fellowship at the Universisty of Colorado, Professor Solomon returned to Peter Mac in 2006, where he now practices as a medical oncologist with a research focus on clinical and translational research in lung cancer and head and neck cancer. His clinical trial work focuses on the identification of novel therapies for lung cancer and he has been involved in clinical trials including trials with novel agents targeting ALK, EGFR, BRAF, cMET, RET, ROS1, NTRK and KRAS. He is a founding director of the Thoracic Oncology Group of Australia and serves on the board of the Cancer Council of Victoria.